Compare ARK Genomic Revolution ETF (ARKG) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs First Citizens BancShares Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.23, while First Citizens BancShares Inc trades at $2,270.44 (market cap $25.26B). The key difference: First Citizens BancShares Inc pays a 0.37% dividend while ARK Genomic Revolution ETF pays none, and First Citizens BancShares Inc is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | FCNCA | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $44.69 | $2.27K |
52-Week Low | $24.02 | $1.64K |
Market Cap | — | $25.26B |
Dividend Yield | — | 0.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
